-
PurposePresentER minigene encoding H2-Kb ligand SIINFEKL (mCherry)
-
Depositing Lab
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 102945 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonePresentER
- Backbone size w/o insert (bp) 8200
- Total vector size (bp) 8321
-
Vector typeMammalian Expression, Retroviral
-
Selectable markersPuromycin ; mCherry
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameSIINFEKL
-
Alt nameChicken Ovalbumin H2-Kd epitope 257-264
-
Alt nameOVA257-264
-
Alt nameOVAL
-
SpeciesG. gallus (chicken), Synthetic
-
Insert Size (bp)24
-
MutationOVA257-264
-
Entrez GeneOVAL (a.k.a. OVA, SERPINB14)
- Promoter LTR
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site SfiI (not destroyed)
- 3′ cloning site SfiI (not destroyed)
- 5′ sequencing primer GTTCGACCCCGCCTCGATCC (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please visit https://www.biorxiv.org/content/early/2018/09/22/267047 for bioRxiv preprint.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
PresentER-SIINFEKL (mCherry) was a gift from David Scheinberg (Addgene plasmid # 102945 ; http://n2t.net/addgene:102945 ; RRID:Addgene_102945) -
For your References section:
Rejection of immunogenic tumor clones is limited by clonal fraction. Gejman RS, Chang AY, Jones HF, DiKun K, Hakimi AA, Schietinger A, Scheinberg DA. Elife. 2018 Nov 30;7. pii: 41090. doi: 10.7554/eLife.41090. 10.7554/eLife.41090 PubMed 30499773